Most patients in the control group received other GLP-1 drugs such as semaglutide, which Novo Nordisk sells for diabetes as ...

Novo Nordisk lost its lead in the GLP-1 race, but Eli Lilly's valuation is a bit rich.

Eli Lilly is working on a new GLP-1 drug, and early results suggest it could be a big winner.

Eli Lilly and Company (India) on Thursday announced the launch of its globally popular weight-loss injectable drug, Mounjaro, in India. Adults taking the drug with diet and exercise in a controlled ...

Here’s what you need to know about Mounjaro, including eligibility requirements, cost, where to buy the medication online and safety considerations. Mounjaro (active ingredient tirzepatide) is a brand ...

Mounjaro carries a list price of $1,079.77 a month in the U.S., although the amount patients pay largely depends on their insurance plan. The India launch of Eli Lilly's popular weight-loss drug ...

It is thought about 1.6 million people are on weight-loss drugs in the UK. Some patients are able to get the injections ...

Walmart agrees to replace two boxes of Mounjaro after News 2 contacts company about defective pens ...

Eli Lilly & Co. said it will press ahead with global drug launches despite uncertainty over the Trump administration’s ...

France will reimburse the cost of weight-loss drugs prescribed to severely obese patients from mid-June in a ‌first for a ...